Brevan Howard Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
+18,176
| New | +$394K | ﹤0.01% | 1361 |
|
|
2025
Q1 | – | Sell |
-12,817
| Closed | -$267K | – | 1162 |
|
|
2024
Q4 | $267K | Sell |
12,817
-7,252
| -36% | -$151K | ﹤0.01% | 787 |
|
|
2024
Q3 | $399K | Sell |
20,069
-9,739
| -33% | -$194K | ﹤0.01% | 700 |
|
|
2024
Q2 | $462K | Buy |
+29,808
| New | +$462K | ﹤0.01% | 589 |
|
|
2024
Q1 | – | Sell |
-32,992
| Closed | -$555K | – | 1009 |
|
|
2023
Q4 | $555K | Buy |
+32,992
| New | +$555K | 0.01% | 392 |
|